AEON Biopharma, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q2 2022 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
AEON Biopharma, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2022 to Q3 2023.
  • AEON Biopharma, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $0 $0 Jul 22, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $0 -$17K -100% Jul 1, 2023 Jul 21, 2023 10-Q/A 2024-03-29
Q2 2023 $91.7K +$74.7K +440% Apr 1, 2023 Jun 30, 2023 10-Q 2023-07-21
Q1 2023 $405K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-17
Q3 2022 $0 Jul 1, 2022 Sep 30, 2022 10-Q/A 2024-03-29
Q2 2022 $17K Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.